Clinical Trial Update: A 8 Weeks Study to Evaluate Efficacy & Safety of rhNGF vs Vehicle in Patients After Cataract and Refractive Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial comparing rhNGF to vehicle in patients with ocular discomfort after cataract and refractive surgery completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract-related Ocular Surface Discomfort
• Ocular Discomfort

Drugs mentioned

• rhNGF (recombinant human nerve growth factor)

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: Ocular Discomfort | Phase 2 | Status: COMPLETED | Results posted: 2019-07-22